Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |